SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 99,000
+4,200 (4.43%)
At close: Apr 1, 2026
-0.30% (1Y)
| Market Cap | 7.75T -13.0% |
| Revenue (ttm) | 706.74B +29.1% |
| Net Income | 266.95B +10.9% |
| EPS | 3,408.75 +10.9% |
| Shares Out | 78.31M |
| PE Ratio | 29.04 |
| Forward PE | 29.32 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 252,601 |
| Average Volume | 766,879 |
| Open | 96,800 |
| Previous Close | 94,800 |
| Day's Range | 96,400 - 99,500 |
| 52-Week Range | 86,900 - 144,100 |
| Beta | 0.76 |
| RSI | 46.99 |
| Earnings Date | May 11, 2026 |